nab-Paclitaxel/Carboplatin in Vulnerable Populations With Advanced Non-Small Cell Lung Cancer: Pooled Analysis

Overview

cited authors

Langer, Corey J.; Gajra, Ajeet; Gridelli, Cesare; Konduri, Kartik; Morgensztern, Daniel; Spigel, David; Talbot, Denis; Thomas, Michael; Weiss, Jared; Pilot, Richard; Bhore, Rafia; Wolfsteiner, Marianne; Ong, Teng Jin; Socinski, Mark

authors

Socinski, Mark A., MD

Publication Date

January 26, 2021

webpage

Web of Science

published in

FRONTIERS IN ONCOLOGY Journal

Research

keywords

advanced non-small cell lung cancer
chemotherapy
nab-Paclitaxel
platinum-based therapy
vulnerable populations

301 E Princeton St., Orlando, FL 32804 | FH.RAS@AdventHealth.com | 407-200-2901

The information on this website is not a substitute for examination, diagnosis, and medical care provided by a licensed and qualified health professional. Please consult your physician before undertaking any form of medical treatment and/or adopting any exercise program or dietary guidelines. If you think you may have a medical emergency, call your physician or 911 immediately. AdventHealth Research Institute reserves the right to add, remove or edit content on this page at its sole discretion.